Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$15.77 - $19.03 $633,954 - $765,006
-40,200 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$16.86 - $23.44 $43,836 - $60,944
-2,600 Reduced 6.07%
40,200 $931,000
Q1 2020

May 15, 2020

BUY
$14.47 - $27.96 $228,626 - $441,768
15,800 Added 58.52%
42,800 $764,000
Q4 2019

Feb 11, 2020

SELL
$15.87 - $23.12 $866,787 - $1.26 Million
-54,618 Reduced 66.92%
27,000 $583,000
Q3 2019

Nov 07, 2019

BUY
$16.91 - $36.27 $86,241 - $184,977
5,100 Added 6.67%
81,618 $1.49 Million
Q2 2019

Aug 01, 2019

SELL
$31.0 - $36.3 $239,413 - $280,344
-7,723 Reduced 9.17%
76,518 $2.72 Million
Q1 2019

May 08, 2019

BUY
$31.58 - $46.35 $13,484 - $19,791
427 Added 0.51%
84,241 $2.83 Million
Q4 2018

Feb 01, 2019

SELL
$30.43 - $56.65 $161,431 - $300,528
-5,305 Reduced 5.95%
83,814 $2.76 Million
Q3 2018

Nov 01, 2018

SELL
$46.46 - $68.49 $258,968 - $381,763
-5,574 Reduced 5.89%
89,119 $5.43 Million
Q2 2018

Jul 31, 2018

SELL
$46.25 - $104.45 $1.52 Million - $3.44 Million
-32,927 Reduced 25.8%
94,693 $4.62 Million
Q1 2018

May 11, 2018

BUY
$57.4 - $108.44 $6.02 Million - $11.4 Million
104,820 Added 459.74%
127,620 $13.6 Million
Q4 2017

Feb 02, 2018

BUY
$23.02 - $60.5 $524,856 - $1.38 Million
22,800
22,800 $1.36 Million

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $174M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.